Arvee Laboratories IPO vs Hindcon Chemicals IPO

Comparison between Arvee Laboratories IPO and Hindcon Chemicals IPO.

IPO Details

Arvee Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Hindcon Chemicals IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Arvee Laboratories IPO is up to ₹8.44 Cr whereas the issue size of the Hindcon Chemicals IPO is up to ₹7.32 Cr. The final issue price of Arvee Laboratories IPO is ₹61.00 per share and of Hindcon Chemicals IPO is ₹28.00 per share.

 Arvee Laboratories IPOHindcon Chemicals IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹61.00 per share₹28.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size2000 shares4000 shares
Fresh Issue Size13,84,000 shares26,16,000 shares
Fresh Issue Size (Amount)up to ₹8.44 Crup to ₹7.32 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total13,84,000 shares26,16,000 shares
Issue Size Total (Amount)up to ₹8.44 Crup to ₹7.32 Cr

IPO Timetable

Arvee Laboratories IPO opens on Feb 09, 2018, while Hindcon Chemicals IPO opens on Feb 26, 2018. The closing date of Arvee Laboratories IPO and Hindcon Chemicals IPO is Feb 14, 2018, and Feb 28, 2018, respectively.

 Arvee Laboratories IPOHindcon Chemicals IPO
Issue OpenFeb 09, 2018Feb 26, 2018
Issue CloseFeb 14, 2018Feb 28, 2018
Basis Of Allotment (Tentative)Feb 19, 2018Mar 06, 2018
Listing date (Tentative)Feb 22, 2018Mar 09, 2018

Financials & KPIs

Arvee Laboratories IPO P/E ratio is , as compared to Hindcon Chemicals IPO P/E ratio of .

 Arvee Laboratories IPOHindcon Chemicals IPO
Financials

Company Financials (Restated Standalone)

Period Ended30 Sep 201731 Mar 201731 Mar 201631 Mar 2015
Assets39.1735.6735.2126.03
Total Income19.8034.9426.9213.05
Profit After Tax0.321.550.19-1.65
NET Worth4.494.192.641.41
Reserves and Surplus0.440.14-1.41-1.59
Total Borrowing24.0523.8023.6620.78
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended30 Sep 201731 Mar 201731 Mar 201631 Mar 2015
Assets29.5625.6224.2325.18
Total Income18.1334.2533.4534.96
Profit After Tax2.192.060.860.34
NET Worth17.0414.8512.7911.93
Reserves and Surplus9.5613.3611.3010.44
Total Borrowing6.424.995.258.91
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100.00%85.13%
Promoter Shareholding (Post-Issue)73.50%62.18%
Market Cap₹33.61 Cr.₹28.67 Cr.

Shares Offered

In the Arvee Laboratories IPO Retail Individual Investors (RII) are offered 6,92,000 shares while in Hindcon Chemicals IPO retail investors are offered 6,92,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Arvee Laboratories IPO and 0 shares in Hindcon Chemicals IPO.

 Arvee Laboratories IPOHindcon Chemicals IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation76,000 shares1,44,000 shares
QIB0 shares0 shares
NII6,92,000 shares13,08,000 shares
RII6,92,000 shares13,08,000 shares
Employee0 shares0 shares
Total13,84,000 shares26,16,000 shares

Bids Received (Subscription)

Arvee Laboratories IPO subscribed 2.90x in total, whereas Hindcon Chemicals IPO subscribed 137.63x.

 Arvee Laboratories IPOHindcon Chemicals IPO
NII (times)2.18x154.85x
RII (times)3.62x120.41x
Total (times)2.90x137.63x

Compare with others

Compare:

Arvee Laboratories IPO Vs Hindcon Chemicals IPO